98%
921
2 minutes
20
Purpose: The middle meningeal artery (MMA) is the target arteries for the treatment of intracranial diseases. The purpose of this study was to investigate the ability of photon-counting detector CT (PCD-CT) to improve the visualization of the MMA compared to energy-integrated detector CT (EID-CT).
Methods: We retrospectively analyzed head CT angiography images from patients who underwent PCD-CT with ultra-high-resolution (UHR) mode between April 2023 and July 2024. We compared the images reconstructed with a slice thickness 0.2 mm and the matrix sizes 1024 × 1024 ('PCD-1024') and 512 × 512 ('PCD-512') with the same-patient images previously obtained by EID-CT with 0.75- or 1.0- mm slice thickness and the matrix size 512 × 512 ('EID-512'). Quantitatively, a region of interest (ROI) was placed on the maxillary artery near the origin of the MMA, and the signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and contrast ratio (CR) were measured. Image sharpness was evaluated by measuring the full width at half maximum (FWHM) and the maximum intensity from the MMA vessel line profile. Qualitatively, the overall image quality, sharpness, and artifacts were evaluated using four-point Likert scales. The same evaluation was performed using PCD-CT with 0.2 mm ('0.2 mm') and virtual monoenergetic images (VMIs) ('45 keV', '55 keV', and '70 keV').
Results: 30 patients (19 males, 11 females; median age 65 years) were included. Quantitatively, the SNR (mean ± SD) for PCD-1024, PCD-512, and EID-512 were 16.9 ± 5.6, 20.3 ± 6.2, and 23.2 ± 7.8, respectively (P < 0.01 for PCD-1024 vs. EID-512). The CNR were 16.6 ± 4.5, 20.2 ± 5.5, and 44.4 ± 13.9. The CR were 0.74 ± 0.06, 0.74 ± 0.06, and 0.68 ± 0.08. The FWHM were 1.41 ± 0.17, 1.48 ± 0.15, and 1.77 ± 0.12, and the maximum intensity were 407.5 ± 71.7, 386.0 ± 72.5, and 218.2 ± 58.2 (P < 0.001 for PCD-1024 vs. EID-512 and PCD-512 vs. EID-512, respectively). Qualitatively, significant differences (P < 0.05) were identified among the PCD-1024, PCD-512, and EID-512 groups regarding the respective scores (median [IQR]) for overall image quality (4 [3-4], 3 [3-4], and 2 [2-3]), sharpness (4 [3-4], 3 [3-3], and 2 [2-3]), and artifacts (3 [3-3], 3 [2-3], and 2 [2-2]). In VMI analysis, quantitatively, 45 keV showed the highest values for SNR, CNR, CR, and maximum intensity; however, there were no differences in FWHM among the groups. Qualitatively, 0.2 mm was superior to the other groups in all evaluated aspects (P < 0.05).
Conclusion: PCD-1024 visualized the MMA better than both PCD-512 and EID-512. The 0.2 mm reconstruction was visually superior to the VMIs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejrad.2025.112155 | DOI Listing |
Clin Neurol Neurosurg
September 2025
Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, USA. Electronic address:
Background: Chronic subdural hematoma (cSDH) is a common neurosurgical condition with a high recurrence rate following surgical evacuation. Middle meningeal artery embolization (MMAE) has emerged as an adjunctive or standalone treatment, but the optimal timing of embolization remains unclear. We evaluated whether early MMAE (≤2 days) versus delayed MMAE (3-7 days) is associated with improved clinical outcomes.
View Article and Find Full Text PDFJ Neurointerv Surg
September 2025
Neurosurgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
Objective: Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters.
View Article and Find Full Text PDFLancet Oncol
September 2025
MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Netwo
Background: TERT promoter mutation is a rare biomarker in meningiomas associated with aberrant TERT expression and reduced progression-free survival. Although high TERT expression is characteristic of tumours with TERT promoter mutations, it has also been observed in tumours with wildtype TERT promoters. This study aimed to investigate the prevalence and prognostic association of TERT expression in meningiomas.
View Article and Find Full Text PDFLancet Oncol
September 2025
Department of Neurosurgery, Mass General Brigham and Harvard Medical School, Boston, MA, USA. Electronic address:
Background: Molecular aberrations have been incorporated into tumour classification guidelines of meningioma. TERT-promoter (TERTp) mutation is associated with worse prognosis and is designated a WHO grade 3 biomarker. However, it remains unclear whether TERTp mutation is context-dependent, with other co-occurring genetic alterations potentially driving its association with prognosis.
View Article and Find Full Text PDFJ Infect Public Health
August 2025
Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medicine - Qatar, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar.
Invasive meningococcal disease (IMD) is associated with significant morbidity and mortality in all age groups. Globally, reported cases predominantly belong to serogroups A, B, and C. Although serogroup W is less prevalent with regional distribution, it demonstrates shifting epidemiology linked to travel.
View Article and Find Full Text PDF